Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer in a Podium Poster Spotlight Discussion at the 2023 SABCS

INT230-6 demonstrated a systemic increase in the median diversity of T-cell repertoire in patients' blood compared to baseline that was also much larger than a...

Related Keywords

Ottawa ,Ontario ,Canada ,California ,United States ,San Francisco ,Dallas ,Texas ,Jonathan Nugent ,Lewish Bender ,Merck Sharpe Dohme ,Bristol Myers Squibb ,Angel Arnaout ,David Rosen ,Sangeetha Reddy ,Intensity Therapeutics Inc ,Ottawa Hospital Research Institute ,Nasdaq ,University Of Ottawa ,Prnewswire Intensity Therapeutics Inc ,Ontario Institute Of Cancer Research ,Ut Southwestern Medical Center ,Ontario Institute For Cancer Research Network ,Ontario Institute For Cancer Research ,Podium Poster Spotlight ,Antonio Breast Cancer Symposium ,Poster Spotlight Session Block ,Triple Negative Breast Cancer ,Novel Therapies ,Night Ballroom ,Ontario Institute ,Medical Center ,Breast Surgical Oncologist ,Ottawa Hospital ,Cancer Research ,Melanie Spears ,Diagnostic Development ,Window Of Opportunity Network ,Chief Executive Officer ,Merck Sharpe ,Investigational New Drug ,Relations Contact ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Trade Show News ,Clinical Trials Amp Medical Discoveries ,